Understanding Underreporting of Adverse Drug Reactions in the Philippines: A Mixed Methods Study
This study reveals significant knowledge gaps among HCPs in the Philippines regarding ADR reporting. While HCPs acknowledge the importance of ADR reporting for patient safety, many perceive the process as complex and burdensome, which discourages consistent participation. The study highlights key barriers, including legal concerns and complexity of online reporting tools. A key policy implication is the need for government agencies, such as the Food and Drug Administration (FDA) and the Department of Health (DOH), to simplify the ADR reporting process and enhance the design of reporting tools, making them more user-friendly and efficient for healthcare professionals.
Authors
- Maria Glezilda R Soriano
- M Adamson (ORCID: https://orcid.org/0000-0002-8990-7017)
- Rizza Ann A. Oquendo
- Mark Ryann A. Lirasan (ORCID: https://orcid.org/0009-0003-8902-8519)
- J Gutierrez-Carmona Francisco
- Vieno Gino Cruz
- Julie Ann T Capuchino
- Leslee Ann Lorna D De Jesus
- Roland Amiel C Peñaloza
- Maureen Allysandra G Gulmatico
- John Eric R Valiente
Institutions
- Philippine Women's University (PH)
- Food and Drug Administration (TH)
Publication Details
- Journal
- Drugs - Real World Outcomes
- Published
- 2025-05-30
- DOI
- https://doi.org/10.1007/s40801-025-00492-z
- Citations
- 1
- Primary Topic
- Pharmacovigilance and Adverse Drug Reactions
- Type
- article
- Field-Weighted Citation Impact
- 1.31
Funders
- UNICEF